These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 30827271)

  • 1. Epigenetic Modifications Associated with the Pathogenesis of Type 2 Diabetes Mellitus.
    Hossan T; Kundu S; Alam SS; Nagarajan S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):775-786. PubMed ID: 30827271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic mechanisms underlying the toxic effects associated with arsenic exposure and the development of diabetes.
    Khan F; Momtaz S; Niaz K; Hassan FI; Abdollahi M
    Food Chem Toxicol; 2017 Sep; 107(Pt A):406-417. PubMed ID: 28709971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell- and tissue-specific epigenetic changes associated with chronic inflammation in insulin resistance and type 2 diabetes mellitus.
    Naidoo V; Naidoo M; Ghai M
    Scand J Immunol; 2018 Dec; 88(6):e12723. PubMed ID: 30589455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Regulation of β Cell Identity and Dysfunction.
    Sun X; Wang L; Obayomi SMB; Wei Z
    Front Endocrinol (Lausanne); 2021; 12():725131. PubMed ID: 34630329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: A systematic review.
    Muka T; Nano J; Voortman T; Braun KVE; Ligthart S; Stranges S; Bramer WM; Troup J; Chowdhury R; Dehghan A; Franco OH
    Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):553-566. PubMed ID: 27146363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation: An Epigenetic Insight into Type 2 Diabetes Mellitus.
    Alam F; Islam MA; Gan SH; Mohamed M; Sasongko TH
    Curr Pharm Des; 2016; 22(28):4398-419. PubMed ID: 27229720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in β-cell adaptation and type 2 diabetes.
    Kim H; Kulkarni RN
    Curr Opin Pharmacol; 2020 Dec; 55():125-131. PubMed ID: 33232934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does epigenetic dysregulation of pancreatic islets contribute to impaired insulin secretion and type 2 diabetes?
    Dayeh T; Ling C
    Biochem Cell Biol; 2015 Oct; 93(5):511-21. PubMed ID: 26369706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking a role of lncRNAs (long non-coding RNAs) with insulin resistance, accelerated senescence, and inflammation in patients with type 2 diabetes.
    Sathishkumar C; Prabu P; Mohan V; Balasubramanyam M
    Hum Genomics; 2018 Aug; 12(1):41. PubMed ID: 30139387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes.
    Ding Q; Gao Z; Chen K; Zhang Q; Hu S; Zhao L
    Front Immunol; 2022; 13():883410. PubMed ID: 35603204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.
    Jazieh C; Arabi TZ; Asim Z; Sabbah BN; Alsaud AW; Alkattan K; Yaqinuddin A
    Front Endocrinol (Lausanne); 2024; 15():1295967. PubMed ID: 38323108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-125b-5p improves pancreatic β-cell function through inhibiting JNK signaling pathway by targeting DACT1 in mice with type 2 diabetes mellitus.
    Yu CY; Yang CY; Rui ZL
    Life Sci; 2019 May; 224():67-75. PubMed ID: 30684546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus.
    Sommese L; Zullo A; Mancini FP; Fabbricini R; Soricelli A; Napoli C
    Epigenetics; 2017 Jun; 12(6):401-415. PubMed ID: 28059593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could lncRNAs contribute to β-cell identity and its loss in Type 2 diabetes?
    Pullen TJ; Rutter GA
    Biochem Soc Trans; 2013 Jun; 41(3):797-801. PubMed ID: 23697940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of histone deacetylase 3 (
    Sathishkumar C; Prabu P; Balakumar M; Lenin R; Prabhu D; Anjana RM; Mohan V; Balasubramanyam M
    Clin Epigenetics; 2016; 8():125. PubMed ID: 27904654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of insulin action and secretion - role in the pathogenesis of type 2 diabetes.
    Ling C
    J Intern Med; 2020 Aug; 288(2):158-167. PubMed ID: 32363639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics: the missing link to understanding β-cell dysfunction in the pathogenesis of type 2 diabetes.
    Gilbert ER; Liu D
    Epigenetics; 2012 Aug; 7(8):841-52. PubMed ID: 22810088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of DNA methylation in the pathogenesis of type 2 diabetes mellitus.
    Ahmed SAH; Ansari SA; Mensah-Brown EPK; Emerald BS
    Clin Epigenetics; 2020 Jul; 12(1):104. PubMed ID: 32653024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key Relevance of Epigenetic Programming of Adiponectin Gene in Pathogenesis of Metabolic Disorders.
    Un Nisa K; Reza MI
    Endocr Metab Immune Disord Drug Targets; 2020; 20(4):506-517. PubMed ID: 31368881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.